GSK and others’ paroxetine deal broke competition law, tribunal says
GSK and other generic suppliers of paroxetine broke competition law with a “pay for delay” deal on antidepressant paroxetine, the Competition Appeal Tribunal (CAT) has concluded.
GSK and other generic suppliers of paroxetine broke competition law with a “pay for delay” deal on antidepressant paroxetine, the Competition Appeal Tribunal (CAT) has concluded.